No Matches Found
No Matches Found
No Matches Found
Cravatex Ltd
Cravatex Ltd is Rated Strong Sell
Cravatex Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 13 August 2025. However, the analysis and financial metrics discussed below reflect the stock's current position as of 07 April 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Five Consecutive Losses Push Cravatex Ltd to a New 52-Week Low
Cravatex Ltd’s share price declined to a fresh 52-week low of Rs.305 on 30 March 2026, marking a significant milestone in the stock’s ongoing downward trajectory. The stock’s performance has been under pressure amid broader market weakness and company-specific factors, culminating in a notable underperformance relative to its sector and benchmark indices.
Cravatex Ltd is Rated Strong Sell
Cravatex Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 13 August 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 27 March 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.
Cravatex Ltd Falls to 52-Week Low of Rs 310 as Sell-Off Deepens
For the third consecutive session, Cravatex Ltd has closed lower, culminating in a fresh 52-week low of Rs 310 on 23 Mar 2026. This decline comes amid a broader market downturn, but the stock’s underperformance has been more pronounced, reflecting company-specific pressures.
Why is Cravatex Ltd falling/rising?
On 20-Mar, Cravatex Ltd’s stock price fell sharply by 3.68% to close at ₹323.00, continuing a recent downward trend that has seen the share price approach its 52-week low. This decline reflects a combination of technical weakness and subdued investor interest, as the stock underperformed both its sector and the broader market benchmarks.
Cravatex Ltd is Rated Strong Sell
Cravatex Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 13 August 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 15 March 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook.
Cravatex Ltd is Rated Strong Sell
Cravatex Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 13 August 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 04 March 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.
Cravatex Ltd is Rated Strong Sell
Cravatex Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 13 August 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 21 February 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trend, and technical outlook.
Are Cravatex Ltd latest results good or bad?
Cravatex Ltd's latest results show mixed performance, with a 13.44% year-on-year sales growth but a significant 28.49% decline from the previous quarter, and a net profit heavily reliant on non-operating income, indicating ongoing operational challenges and inefficiencies. Overall, the company is struggling with persistent losses and a declining revenue trajectory.
Cravatex Q3 FY26: Profit Surge Masks Persistent Operating Weakness
Cravatex Limited, the Mumbai-based sports goods and fitness equipment distributor with a market capitalisation of ₹95.00 crores, reported a net profit of ₹1.35 crores for Q3 FY26, representing a remarkable 440.00% year-on-year growth from ₹0.25 crores in Q3 FY25. However, this apparent profitability turnaround conceals a troubling reality: the company remains fundamentally unprofitable at the operating level, with its bottom line propped up almost entirely by non-operating income.
Are Cravatex Ltd latest results good or bad?
Cravatex Ltd's latest results show a net profit increase of 96.98% to ₹5.22 crores, largely driven by non-operating income, but revenue declined by 6.52% to ₹51.45 crores, indicating ongoing operational challenges. While profit margins improved, the reliance on non-operating income and declining sales raise concerns about long-term sustainability.
Cravatex Ltd is Rated Strong Sell
Cravatex Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 13 August 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 10 February 2026, providing investors with the most up-to-date insight into the stock’s fundamentals, valuation, financial trends, and technical outlook.
Cravatex Ltd is Rated Strong Sell
Cravatex Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 13 August 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 30 January 2026, providing investors with the latest insights into the company’s performance and outlook.
Cravatex Ltd is Rated Strong Sell
Cravatex Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 13 August 2025, reflecting a shift from the previous 'Sell' grade. However, the analysis and financial metrics presented here are based on the stock's current position as of 19 January 2026, providing investors with the latest insights into the company’s performance and outlook.
Cravatex Ltd is Rated Strong Sell
Cravatex Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 13 Aug 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 06 January 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Cravatex Ltd is Rated Strong Sell
Cravatex Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 13 August 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 December 2025, providing investors with the latest insights into the company’s performance and outlook.
Cravatex Sees Revision in Market Evaluation Amidst Challenging Financial Trends
Cravatex, a microcap player in the Trading & Distributors sector, has experienced a notable revision in its market evaluation, reflecting shifts in its fundamental and technical outlook. This adjustment follows a period marked by subdued sales growth, challenging profitability metrics, and persistent underperformance relative to broader market benchmarks.
Why is Cravatex falling/rising?
As of 17-Nov, Cravatex Ltd's stock price is at 399.50, up 4.84% today, but down 9.40% year-to-date. The stock shows strong short-term performance, outperforming the Sensex, though it has faced significant declines over the past year and a drop in delivery volume.
Cravatex Q2 FY26: Strong Profit Surge Masks Underlying Operational Challenges
Cravatex Limited, the Mumbai-based sports goods and fitness equipment distributor, reported a remarkable 96.98% year-on-year surge in net profit to ₹5.22 crores for Q2 FY26, compared to ₹2.65 crores in the corresponding quarter last year. However, this impressive bottom-line growth conceals troubling operational realities that have left investors concerned about the company's fundamental health. The stock has declined 6.52% year-on-year alongside deteriorating sales performance, trading at ₹399.50 with a market capitalisation of ₹103.00 crores.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
